Journal articles on the topic 'Population screening'

To see the other types of publications on this topic, follow the link: Population screening.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Population screening.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Beutler, Ernest. "Hemochromatosis Population Screening." Genetic Testing 4, no. 2 (June 19, 2000): 95–96. http://dx.doi.org/10.1089/10906570050114768.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zheng, Senshuang, Xiaorui Zhang, Marcel J. W. Greuter, Geertruida H. de Bock, and Wenli Lu. "Determinants of Population-Based Cancer Screening Performance at Primary Healthcare Institutions in China." International Journal of Environmental Research and Public Health 18, no. 6 (March 23, 2021): 3312. http://dx.doi.org/10.3390/ijerph18063312.

Full text
Abstract:
Background: For a decade, most population-based cancer screenings in China are performed by primary healthcare institutions. To assess the determinants of performance of primary healthcare institutions in population-based breast, cervical, and colorectal cancer screening in China. Methods: A total of 262 primary healthcare institutions in Tianjin participated in a survey on cancer screening. The survey consisted of questions on screening tests, the number of staff members and training, the introduction of the screening programs to residents, the invitation of residents, and the number of performed screenings per year. Logistic regression models were used to analyze the determinants of performance of an institution to fulfil the target number of screenings. Results: In 58% and 61% of the institutions between three and nine staff members were dedicated to breast and cervical cancer screening, respectively, whereas in 71% of the institutions ≥10 staff members were dedicated to colorectal cancer screening. On average 60% of institutions fulfilled the target number of breast and cervical cancer screenings, whereas 93% fulfilled the target number for colorectal cancer screening. The determinants of performance were rural districts for breast (OR = 5.16 (95%CI: 2.51–10.63)) and cervical (OR = 4.17 (95%CI: 2.14–8.11)) cancer screenings, and ≥3 staff members dedicated to cervical cancer screening (OR = 2.34 (95%CI: 1.09–5.01)). Conclusions: Primary healthcare institutions in China perform better in colorectal than in breast and cervical cancer screening, and institutions in rural districts perform better than institutions in urban districts. Increasing the number of staff members on breast and cervical cancer screening could improve the performance of population-based cancer screening.
APA, Harvard, Vancouver, ISO, and other styles
3

Gruwez, Henri, Tine Proesmans, Stijn Evens, Frederik H. Verbrugge, Sébastien Deferm, Jeroen Dauw, Rik Willems, Pieter Vandervoort, Peter Haemers, and Laurent Pison. "Atrial Fibrillation Population Screening." Cardiac Electrophysiology Clinics 13, no. 3 (September 2021): 531–42. http://dx.doi.org/10.1016/j.ccep.2021.04.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fordham, J. N., and R. Madhok. "Population screening for osteoporosis." Quality and Safety in Health Care 1, no. 2 (June 1, 1992): 140–41. http://dx.doi.org/10.1136/qshc.1.2.140-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Heck, Patrick R., and Michelle N. Meyer. "Population Whole Exome Screening." Medical Clinics of North America 103, no. 6 (November 2019): 1077–92. http://dx.doi.org/10.1016/j.mcna.2019.08.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

ADAMS, P. C. "Population screening for haemochromatosis." Gut 46, no. 3 (March 1, 2000): 301–3. http://dx.doi.org/10.1136/gut.46.3.301.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Benett, I. J. "Population Screening for Diabetes." Diabetic Medicine 11, no. 5 (June 1994): 517–18. http://dx.doi.org/10.1111/j.1464-5491.1994.tb00319.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Price, J. L., and A. E. Kirkpatrick. "Population screening by mammography." Clinical Radiology 39, no. 4 (July 1988): 465. http://dx.doi.org/10.1016/s0009-9260(88)80317-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tucker, A. K. "Population screening by mammography." Clinical Radiology 39, no. 4 (July 1988): 465. http://dx.doi.org/10.1016/s0009-9260(88)80318-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Walker, W. J. "Population screening by mammography." Clinical Radiology 39, no. 1 (January 1988): 104. http://dx.doi.org/10.1016/s0009-9260(88)80366-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Tucker, A. K. "Population screening by mammography." Clinical Radiology 39, no. 1 (January 1988): 104. http://dx.doi.org/10.1016/s0009-9260(88)80367-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Champion, Victoria L., Susan M. Rawl, and Usha Menon. "Population-Based Cancer Screening." Oncology Nursing Forum 29, no. 5 (January 1, 2002): 853–61. http://dx.doi.org/10.1188/02.onf.853-861.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Paci, Eugenio, F. E. Alexander, T. J. Anderson, Matti Hakama, Hazel Thornton, N. E. Day, L. Tabar, S. W. Duffy, and H. H. Chen. "Population breast-cancer screening." Lancet 345, no. 8953 (April 1995): 853–55. http://dx.doi.org/10.1016/s0140-6736(95)92988-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Goonasekera, H. W., C. S. Paththinige, and V. H. W. Dissanayake. "Population Screening for Hemoglobinopathies." Annual Review of Genomics and Human Genetics 19, no. 1 (August 31, 2018): 355–80. http://dx.doi.org/10.1146/annurev-genom-091416-035451.

Full text
Abstract:
Hemoglobinopathies are the most common single-gene disorders in the world. Their prevalence is predicted to increase in the future, and low-income hemoglobinopathy-endemic regions need to manage most of the world's affected persons. International organizations, governments, and other stakeholders have initiated national or regional prevention programs in both endemic and nonendemic countries by performing population screening for α- and β-thalassemia, HbE disease, and sickle cell disease in neonates, adolescents, reproductive-age adults (preconceptionally or in the early antenatal period), and family members of diagnosed cases. The main aim of screening is to reduce the number of affected births and, in the case of sickle cell disease, reduce childhood morbidity and mortality. Screening strategies vary depending on the population group, but a few common screening test methods are universally used. We discuss the salient features of population-screening programs around the globe as well as current and proposed screening test methodologies.
APA, Harvard, Vancouver, ISO, and other styles
15

Benito, Llucia, Jose Espinosa, Gemma Binefa, Carmen Vidal, María Teresa Lluch, Montse Puig, Maria Fernandez, Isabel Padrol, and Montse García. "Population-based Cancer Screening." Cancer Nursing 41, no. 4 (2018): E1—E11. http://dx.doi.org/10.1097/ncc.0000000000000514.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Cao, Antonio, Maria Cristina Rosatelli, and Renzo Galanello. "Population-based genetic screening." Current Opinion in Genetics & Development 1, no. 1 (June 1991): 48–53. http://dx.doi.org/10.1016/0959-437x(91)80040-s.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

King, Mary-Claire, Ephrat Levy-Lahad, and Amnon Lahad. "Population-Based Screening forBRCA1andBRCA2." JAMA 312, no. 11 (September 17, 2014): 1091. http://dx.doi.org/10.1001/jama.2014.12483.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Adams, Paul C. "Population screening for hemochromatosis." Hepatology 29, no. 4 (April 1999): 1324–27. http://dx.doi.org/10.1002/hep.510290425.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Murray, Michael F., James P. Evans, and Muin J. Khoury. "DNA-Based Population Screening." JAMA 323, no. 4 (January 28, 2020): 307. http://dx.doi.org/10.1001/jama.2019.18640.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Levenson, Deborah. "Population screening beyond newborns." American Journal of Medical Genetics Part A 152A, no. 3 (March 2010): fm viii—fm ix. http://dx.doi.org/10.1002/ajmg.a.33288.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Weber, Jennifer E., and Mark Guiberson. "Recommended Audiometric Screening Strategies With Preschool-Age English Language Learners." Perspectives on Communication Disorders and Sciences in Culturally and Linguistically Diverse (CLD) Populations 18, no. 3 (October 2011): 57–62. http://dx.doi.org/10.1044/cds18.3.57.

Full text
Abstract:
This article describes the increase of English language learners (ELLs) in the preschool population across the United States and the pressing need for audiologists and other individuals performing preschool hearing screenings to adequately screen this population. The authors then present a university-based, regional, early childhood collaborative screening program. The authors also present general strategies for screening preschool-age populations as well as specific strategies to screen the audiometric status of young ELLs.
APA, Harvard, Vancouver, ISO, and other styles
22

Reddy, Dr M. Mamatha, Dr K. Swarnalatha, Dr Manisha Sahay, and Dr G. Sasikala. "Cost effectiveness of screening tests for UTI in CKD population." Scholars Journal of Applied Medical Sciences 4, no. 7 (July 2016): 2665–73. http://dx.doi.org/10.21276/sjams.2016.4.7.76.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

McCabe, Linda L., and Edward R. B. McCabe. "Newborn screening as a model for population screening." Molecular Genetics and Metabolism 75, no. 4 (April 2002): 299–307. http://dx.doi.org/10.1016/s1096-7192(02)00005-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Reungwetwattana, Thanyanan, Julian R. Molina, and Jeanette Y. Ziegenfuss. "Factors and trends in cancer screening in the United States from 2004 to 2010." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 1565. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1565.

Full text
Abstract:
1565 Background: Understanding the prevalence of cancer screening in the US and the factors associated with its accessibility is important for public health promotion. Methods: The 2004 and 2010 Behavioral Risk Factor Surveillance Systems were used to ascertain cancer screening rates among populations indicated for each test by age, gender, and the American Cancer Society recommendation for cancer screenings [fecal occult blood test (FOBT) or endoscopy for colorectal cancer (CRC) screening, digital rectal examination (DRE) or prostate specific antigen (PSA) for prostate cancer screening, clinical breast examination (CBE) or mammogram for breast cancer screening, and Papanicolaou (Pap) test for cervical cancer screening]. Results: Over this period, CRC and breast cancer screening rates significantly increased (15.9%, 13.9%) while prostate and cervical cancer screening rates significantly decreased (1.2%, 5.2%). Race/ethnicity might be an influence in CRC and cervical cancer screening accessibility. Prostate cancer screening accessibility might be influenced by education and income. The older-aged populations (70-79, >79) had high prevalence of CRC, prostate and breast cancer screenings even though there is insufficient evidence for the benefits and harms of screenings in the older-aged group. Conclusions: The disparities in age, race/ethnicity, health insurance, education, employment, and income for the accession to cancer screening of the US population have decreased since 2004. The trajectory of increasing rates of CRC and breast cancer screenings should be maintained. To reverse the trend, the causes of the decreased rate of cervical cancer screening and the high rates of screenings in older-aged populations should, however, be further explored. [Table: see text]
APA, Harvard, Vancouver, ISO, and other styles
25

Powe, Neil R., and L. Ebony Boulware. "Population-Based Screening for CKD." American Journal of Kidney Diseases 53, no. 3 (March 2009): S64—S70. http://dx.doi.org/10.1053/j.ajkd.2008.07.050.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Schabas, Richard. "Population Screening for Colorectal Cancer." Journal of Psychosocial Oncology 19, no. 3-4 (December 3, 2001): 21–28. http://dx.doi.org/10.1300/j077v19n03_03.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Foster, Carl. "Population Screening for Plasma Cholesterol." Journal of Cardiopulmonary Rehabilitation 9, no. 7 (July 1989): 292. http://dx.doi.org/10.1097/00008483-198907000-00007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Motulsky, Arno G., and Ernest Beutler. "Population Screening in Hereditary Hemochromatosis." Annual Review of Public Health 21, no. 1 (May 2000): 65–79. http://dx.doi.org/10.1146/annurev.publhealth.21.1.65.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

TURNER, GILLIAN, HAZEL ROBINSON, SUE LANG, MARY VAN DEN BERK, ALLISON COLLEY, ANDREA GODDARD, STEPHANIE SHERMAN, and MICHAEL PARTINGTON. "Population Screening for Fragile X." Obstetrical & Gynecological Survey 48, no. 1 (January 1993): 32–33. http://dx.doi.org/10.1097/00006254-199301000-00012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Murray, Alexandra, and Angus Clarke. "The ethics of population screening." Current Paediatrics 12, no. 6 (December 2002): 447–52. http://dx.doi.org/10.1054/cupe.2002.0334.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Brock, David J. H. "Population screening for cystic fibrosis." Current Opinion in Pediatrics 8, no. 6 (December 1996): 635–38. http://dx.doi.org/10.1097/00008480-199612000-00016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Schilsky, Michael L., and Benjamin Shneider. "Population screening for Wilson's disease." Journal of Pediatrics 140, no. 5 (May 2002): 499–501. http://dx.doi.org/10.1067/mpd.2002.124769.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Metcalfe, Sylvia A., and Alison D. Archibald. "Fragile X population carrier screening." Genetics in Medicine 14, no. 3 (March 2012): 350. http://dx.doi.org/10.1038/gim.2011.79.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Paterson, K. R. "Population Screening for Diabetes Mellitus." Diabetic Medicine 10, no. 8 (October 1993): 777–81. http://dx.doi.org/10.1111/j.1464-5491.1993.tb00164.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Gilbert, James, C. D. Ritchie, A. R. Bailey, PaulN Durrington, H. A. W. Neil, D. Mant, and G. H. Fowler. "POPULATION SCREENING FOR SERUM CHOLESTEROL." Lancet 333, no. 8637 (March 1989): 547–48. http://dx.doi.org/10.1016/s0140-6736(89)90082-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Riddell, A. D., and John Beynon. "Population screening for colorectal cancer." Surgery (Oxford) 32, no. 4 (April 2014): 172–78. http://dx.doi.org/10.1016/j.mpsur.2014.02.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Allen, P. I. M., D. Gourevitch, J. Mckinley, D. Tudway, and M. Goldman. "POPULATION SCREENING FOR AORTIC ANEURYSMS." Lancet 330, no. 8561 (September 1987): 736. http://dx.doi.org/10.1016/s0140-6736(87)91090-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Worral, G. "Screening the population for diabetes." BMJ 308, no. 6944 (June 18, 1994): 1639. http://dx.doi.org/10.1136/bmj.308.6944.1639a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Hahn, Si Houn. "Population screening for Wilson's disease." Annals of the New York Academy of Sciences 1315, no. 1 (April 14, 2014): 64–69. http://dx.doi.org/10.1111/nyas.12423.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Tucker, A. K. "Annotation: Population screening by mammography." Clinical Radiology 38, no. 3 (May 1987): 215–16. http://dx.doi.org/10.1016/s0009-9260(87)80045-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Turner, G., H. Robinson, S. Laing, A. Goddard, M. van den Berk, S. Sherman, A. Colley, and M. Partington. "Population screening for fragile X." Lancet 339, no. 8803 (May 1992): 1210–13. http://dx.doi.org/10.1016/0140-6736(92)91142-u.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Flinter, FrancesA, Anne Silver, ChristopherG Mathew, and Martin Bobrow. "Population screening for cystic fibrosis." Lancet 339, no. 8808 (June 1992): 1539–40. http://dx.doi.org/10.1016/0140-6736(92)91304-q.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Metcalfe, Sylvia A., Martin B. Delatycki, Jonathan Cohen, Alison D. Archibald, and Jon D. Emery. "Fragile X population carrier screening." Genetics in Medicine 20, no. 9 (December 7, 2017): 1091–92. http://dx.doi.org/10.1038/gim.2017.209.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Armstrong, Peter, Janet E. Husband, and John A. Holemans. "Population screening for lung cancer." Hospital Medicine 65, no. 7 (July 2004): 404–11. http://dx.doi.org/10.12968/hosp.2004.65.7.15457.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Slowther, Anne. "Predictive testing and population screening." Clinical Ethics 3, no. 1 (March 2008): 11–13. http://dx.doi.org/10.1258/ce.2008.008003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Wynder, Ernst L. "Population Screening for Cholesterol Determination." JAMA 256, no. 20 (November 28, 1986): 2839. http://dx.doi.org/10.1001/jama.1986.03380200077025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Dyson, T. J., D. J. Marshall, and J. D. Hardcastle. "BBC microcomputers in population screening." Journal of Microcomputer Applications 9, no. 2 (April 1986): 151–57. http://dx.doi.org/10.1016/0745-7138(86)90042-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Sobue, Tomotaka. "Recommedation of Breast Cancer Screening as Population-based Screening." Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) 21, no. 1 (2012): 26–32. http://dx.doi.org/10.3804/jjabcs.21.26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Winquist, Brandace, and Nazeem Muhajarine. "PREDICTORS OF PRENATAL SCREENING IN A LOW-SCREENING POPULATION." Journal of Epidemiology and Community Health 67, no. 4 (March 6, 2013): e1.2-e1. http://dx.doi.org/10.1136/jech-2013-202386.2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Omenukor, K. "Cancer Awareness Campaign and Screening." Journal of Global Oncology 4, Supplement 2 (October 1, 2018): 142s. http://dx.doi.org/10.1200/jgo.18.73900.

Full text
Abstract:
Background and context: Colorectal cancer is the 3rd leading cause of cancer-related mortalities, which can be prevented by early screening. However, inadequate knowledge regarding the importance of early screening contributes to low cancer screening rates in the population. Aims: A collaborative initiative between David Omenukor Foundation and Fight Colorectal Cancer Organization strives to cancer awareness and screening in the population. Strategy: The David Omenukor Foundation organized a 5-km WALK-A-THON in Mesquite, Texas, on March 10, 2018, as part of the activities to observe the March Colorectal Cancer Awareness Month. During the event, participants received free screening for colorectal, breast, and prostate cancers. Free cholesterol, diabetes, and blood pressure testing were also done because of the impact of these comorbidities on health outcomes. Education experts on cancer were available to teach aspects of healthy diets and exercise. Two cancer patients and a survivor also shared their experiences. Program/Policy process: The program seeks to increase cancer awareness among populations and promote the culture of early and regular screening. Outcomes: Free colorectal and breast cancer screenings were provided to 270 people. About 60 people received free prostate-specific antigen (PSA) test, whereas 135 people received fecal occult blood testing. Similarly, 75 women received mammogram testing. The total number of patients who received colorectal cancer screening increased from 50 on 11th March 2017 to 135 on March 11th, 2018. Impact: The foundation created awareness of all forms of cancer and emphasized the value of early screening as the most effective to avoid the cancer scourge. The participants benefitted from nutritional advice as one strategy for reducing the risk of colorectal cancer. The event indicated that the campaign on early screening for detection was beginning to catch up. Regular interactive events and screenings increase knowledge of cancer and reduce disparities in cancer screening in the community.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography